NCT07372326 A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients
| NCT ID | NCT07372326 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
| Condition | Stroke Patients With Constipation |
| Study Type | INTERVENTIONAL |
| Enrollment | 105 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 105 participants in total. It began in 2025-05-15 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore the application effect of Ziwu Liuzhu electronic moxibustion combined with auricular points on constipation in stroke patients through clinical controlled trials, as well as the advantages over using electronic moxibustion alone.
Eligibility Criteria
Inclusion criteria: 1. Meets the diagnostic criteria of both Western medicine and traditional Chinese medicine, and has not undergone surgery or other internal medical treatments, with the occurrence of constipation; 2. The condition is stable, without severe clinical complications; 3. Can accept moxibustion treatment, and the local skin is undamaged; 4. Those who agree to participate in this study and sign the informed consent form. Exclusion criteria: 1. Digestive tract disorders, such as intestinal polyps, tuberculosis, and tumors. Irritable bowel syndrome or constipation secondary to organic diseases (such as endocrine, metabolic or post-operative diseases); abdominal aneurysm, hepatosplenomegaly, or severe cardiovascular, liver, kidney or mental disorders and coagulation disorders. 2. The patient had constipation before the stroke. 3. The patient withdrew from the study due to other reasons during the course of the study. Dropout criteria and termination criteria: 1. Patients who have not received the prescribed treatment and whose therapeutic effect cannot be determined; 2. Patients who experience serious adverse events or complications and are not suitable to continue the treatment and thus the trial is terminated; 3. Patients with poor compliance, who withdraw from the treatment during the course of the trial, or who use treatment methods prohibited by this protocol concurrently, or who change the treatment method halfway on their own. Note: For any patient meeting any of the above criteria 1, they will be handled as a dropout case.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07372326 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Stroke Patients With Constipation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07372326 currently recruiting?
Yes, NCT07372326 is actively recruiting participants. Contact the research team at 443678514@qq.com for enrollment information.
Where is the NCT07372326 trial being conducted?
This trial is being conducted at Jinhua, China.
Who is sponsoring the NCT07372326 clinical trial?
NCT07372326 is sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. The trial plans to enroll 105 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.